Single-dose lignocaine-based blood cardioplegia in single valve replacement patients Report as inadecuate




Single-dose lignocaine-based blood cardioplegia in single valve replacement patients - Download this document for free, or read online. Document in PDF available to download.

Amber Malhotra ; Vivek Wadhwa ; Pranav Sharma ; Pankaj Garg ; Malkesh Tarsaria ; Himani Pandya ;Revista Brasileira de Cirurgia Cardiovascular-Brazilian Journal of Cardiovascular Surgery 2017, 32 2

Author: Jaydip Ramani

Source: http://www.redalyc.org/articulo.oa?id=398950486006


Teaser



Revista Brasileira de Cirurgia Cardiovascular-Brazilian Journal of Cardiovascular Surgery ISSN: 0102-7638 revista@sbccv.org.br Sociedade Brasileira de Cirurgia Cardiovascular Brasil Ramani, Jaydip; Malhotra, Amber; Wadhwa, Vivek; Sharma, Pranav; Garg, Pankaj; Tarsaria, Malkesh; Pandya, Himani Single-Dose Lignocaine-Based Blood Cardioplegia in Single Valve Replacement Patients Revista Brasileira de Cirurgia Cardiovascular-Brazilian Journal of Cardiovascular Surgery, vol.
32, núm.
2, 2017, pp.
90-95 Sociedade Brasileira de Cirurgia Cardiovascular São José do Rio Preto, Brasil Available in: http:--www.redalyc.org-articulo.oa?id=398950486006 How to cite Complete issue More information about this article Journals homepage in redalyc.org Scientific Information System Network of Scientific Journals from Latin America, the Caribbean, Spain and Portugal Non-profit academic project, developed under the open access initiative Braz J Cardiovasc Surg 2017;32(2):90-5 ORIGINAL ARTICLE Single-Dose Lignocaine-Based Blood Cardioplegia in Single Valve Replacement Patients Jaydip Ramani1, MD; Amber Malhotra1, MD, PhD; Vivek Wadhwa1, MD; Pranav Sharma1, MD, PhD; Pankaj Garg1, MD; Malkesh Tarsaria1; Himani Pandya2, MD DOI: 10.21470-1678-9741-2016-0025 Abstract were 73.8±16.5 and 76.4±16.9 minutes (P=0.43) and cross clamp time were 58.9±10.3 and 66.3±11.2 minutes (P=0.23) in group 1 and group 2, respectively.
Mean of maximum inotrope score was 6.3±2.52 and 6.1±2.13 (P=0.65) in group 1 and group 2, respectively.
We also did not find any statistically significant difference in creatine-phosphokinaseMB (CPK-MB), Troponin-I levels, lactate level and cardiac functions postoperatively. Conclusion: This study proves the safety and efficacy of longacting lignocaine-based single-dose blood cardioplegia compared to the standard short-acting multi-dose blood cardioplegia in patients requiring the single valve replacement.
Further studies need to be undertaken to establish this non...





Related documents